PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

Biotech Stocks Healthcare Stocks
$28.05
-0.90 (-3.11%)
As of Aug 15, 2:19 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -2.7% upside
Low Target $18.57
Average Target $27.28
High Target $35.01
Current Price $28.05
Current
$28.05
Target
$27.28
$18.57 $27.28 avg $35.01
Scenario Analysis
Bear Case
$18.57
-33.8%
Low target
Base Case
$27.28
-2.7%
Avg target
Bull Case
$35.01
+24.8%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$37.50
-25.2% from high
52-Week Low
$16.50
+70.0% from low
Target vs 52W High
$27.28
-27.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.4%